BRPI0507253A - composição nutricional para melhorar as condições da pele e prevenir doenças de pele - Google Patents

composição nutricional para melhorar as condições da pele e prevenir doenças de pele

Info

Publication number
BRPI0507253A
BRPI0507253A BRPI0507253-0A BRPI0507253A BRPI0507253A BR PI0507253 A BRPI0507253 A BR PI0507253A BR PI0507253 A BRPI0507253 A BR PI0507253A BR PI0507253 A BRPI0507253 A BR PI0507253A
Authority
BR
Brazil
Prior art keywords
skin
nutritional composition
composition
diseases
prevent
Prior art date
Application number
BRPI0507253-0A
Other languages
English (en)
Inventor
Sylvie Pridmore-Merten
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34833551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0507253(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0507253A publication Critical patent/BRPI0507253A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

COMPOSIçãO NUTRICIONAL PARA MELHORAR AS CONDIçõES DA PELE E PREVENIR DOENçAS DE PELE.A presente invenção pertence ao uso de uma compoisção ingerível que contém L-carnitina e pelo menos um componente teno uma atividade antioxidativa para etimular o metabolismo de lipídio na pele de um indivíduo, que resulta em uma melhoria da condição geral da pele em paticular pele seca, reativa ou sensível, e na prevenção da ocorrência de doenças da pele, tal como dermatite. Além disso também, apresente invenção petence ao uso de uma tal composição para a preparação de uma composição farmacêutica ou de um alimento,em particular um alimento funcional ou produto de alimento animal de estimação, para aumentar a segregação de lipídio em sebo, poduzindo uma camada de sebo protetora na pele.
BRPI0507253-0A 2004-01-28 2005-01-27 composição nutricional para melhorar as condições da pele e prevenir doenças de pele BRPI0507253A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04001843 2004-01-28
PCT/EP2005/000808 WO2005074719A1 (en) 2004-01-28 2005-01-27 Nutritional composiition for improving skin condition and preventing skin diseases

Publications (1)

Publication Number Publication Date
BRPI0507253A true BRPI0507253A (pt) 2007-06-26

Family

ID=34833551

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507253-0A BRPI0507253A (pt) 2004-01-28 2005-01-27 composição nutricional para melhorar as condições da pele e prevenir doenças de pele

Country Status (15)

Country Link
US (1) US20080305094A1 (pt)
EP (1) EP1711070B1 (pt)
JP (1) JP2007519678A (pt)
KR (1) KR20060132667A (pt)
CN (1) CN1917779B (pt)
AR (1) AR047649A1 (pt)
AU (1) AU2005211165B8 (pt)
BR (1) BRPI0507253A (pt)
CA (1) CA2553884C (pt)
ES (1) ES2560655T3 (pt)
NO (1) NO20063781L (pt)
PT (1) PT1711070E (pt)
RU (1) RU2350124C2 (pt)
TW (1) TW200628149A (pt)
WO (1) WO2005074719A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
KR20060132667A (ko) 2004-01-28 2006-12-21 네스텍소시에테아노님 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물
JP5264702B2 (ja) * 2006-03-29 2013-08-14 ネステク ソシエテ アノニム プロバイオティクスを含有する栄養補助食品
DE102007009650A1 (de) 2007-02-26 2008-08-28 Beiersdorf Ag Kosmetisches Kombinationsprodukt zur Verbesserung des äußeren Erscheinungsbildes
DE102007009649A1 (de) 2007-02-26 2008-08-28 Beiersdorf Ag Nahrungsergänzungsmittel zur Pflege und/oder Verschönerung der Haut
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
US20100112136A1 (en) * 2008-10-30 2010-05-06 Susan Ruth Ward Pet food composition comprising an antioxidant component
EP2263481A1 (en) * 2009-05-29 2010-12-22 Nestec S.A. Green tea extracts of improved bioavailability
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US9173423B2 (en) * 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
IT1405780B1 (it) * 2010-07-12 2014-01-24 Giuliani Spa Miscela arricchita di isoflavoni-agliconi, equolo e lunasina a base di soia fermentata, procedimento per la sua preparazione e relativi usi in campo alimentare, medico e cosmetico.
US9301973B2 (en) 2010-10-27 2016-04-05 Nestec S.A. Methods and compositions suitable for promoting healthy skin
ITTO20120714A1 (it) * 2012-08-08 2014-02-09 Minerva Res Labs Ltd Integratore alimentare per migliorare la salute del tessuto connettivo
MX2017010324A (es) 2015-02-16 2017-12-07 Mars Inc Croqueta entrelazada.
CA2981754A1 (en) * 2015-04-06 2016-10-13 Shenzhen Hightide Biopharmaceutical, Ltd. Conjugate compounds of ursodeoxycholic, berberine or l-carnitine, and compositions and methods thereof
RU2749423C2 (ru) 2015-04-28 2021-06-10 Марс, Инкорпорейтед Способ получения стерилизованного влажного кормового продукта для домашних животных
CN105327342B (zh) * 2015-11-20 2018-08-28 重庆苗秀生物科技有限公司 一种治疗皮肤湿疹和虫咬皮炎的膏剂及其制备方法
CN108208602A (zh) * 2017-11-29 2018-06-29 兰溪市哥特生物技术有限公司 含有从毛蚶中提取的活性多肽的保健品制备方法
MX2021004937A (es) 2018-11-02 2021-06-08 Unilever Ip Holdings B V Glicerolesteres del acido nicotinico bioenergetico, composiciones y metodos para utilizar el mismo.
JP7478517B2 (ja) * 2019-04-24 2024-05-07 三菱商事ライフサイエンス株式会社 脂質活性代謝改善組成物
TW202114707A (zh) * 2019-07-02 2021-04-16 美商瑪斯公司 動物食物組合物
JP2021010316A (ja) * 2019-07-04 2021-02-04 日本ペットフード株式会社 キャットフード
KR102135551B1 (ko) * 2019-08-29 2020-07-20 주식회사 씨앤피코스메틱스 포름오노네틴을 지표성분으로 포함하는 레드 프로폴리스 추출물을 포함하는 안티에이징 효과가 우수한 화장료 조성물

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839159A (en) 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
IT1283967B1 (it) 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US6348495B1 (en) * 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
US6380252B1 (en) * 1996-07-05 2002-04-30 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
WO1998043617A2 (en) * 1997-03-27 1998-10-08 Sole Michael J Nutritional composition for improvements in cell energetics
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
IT1302125B1 (it) * 1998-08-03 2000-07-31 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
IT1312377B1 (it) 1999-03-05 2002-04-15 Uni Ci S R L Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
US20020077349A1 (en) * 1999-11-03 2002-06-20 Hamilton Nathan D. Method of treating age-related vision impairment
US20030060503A1 (en) * 2000-01-25 2003-03-27 Juvenon, Inc. Nutritional supplements for mature pets
FI111686B (fi) * 2000-04-20 2003-09-15 Simo Rasi Kosmeettinen tai ihonhoidollinen voidekoostumus, sen valmistusmenetelmä ja käyttö
WO2002011717A1 (en) * 2000-08-07 2002-02-14 Juvenon, Inc. Cosmetics to support skin metabolism
WO2002043666A2 (en) * 2000-10-31 2002-06-06 Colgate-Palmolive Company Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
RU2187229C1 (ru) * 2001-04-09 2002-08-20 Государственное научное учреждение Научно-исследовательский институт детского питания РАСХН Кисломолочный продукт для детского питания с рождения до пяти месяцев жизни
DE10129502A1 (de) 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US20040198819A1 (en) * 2001-06-20 2004-10-07 Young Aiping H. Biological response modifier composition and uses thereof
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients
AU2003294667A1 (en) 2002-09-09 2004-04-08 Nestec S.A. Orally administrable composition for improving skin quality
JP2005170834A (ja) * 2003-12-10 2005-06-30 Taiyo Yakuhin Kogyo Kk 皮膚改善製剤
KR20060132667A (ko) 2004-01-28 2006-12-21 네스텍소시에테아노님 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물

Also Published As

Publication number Publication date
TW200628149A (en) 2006-08-16
RU2006130739A (ru) 2008-03-10
CN1917779B (zh) 2010-06-16
AU2005211165A1 (en) 2005-08-18
US20080305094A1 (en) 2008-12-11
EP1711070A1 (en) 2006-10-18
EP1711070B1 (en) 2015-12-09
ES2560655T3 (es) 2016-02-22
CN1917779A (zh) 2007-02-21
AR047649A1 (es) 2006-02-01
PT1711070E (pt) 2016-02-15
JP2007519678A (ja) 2007-07-19
WO2005074719A1 (en) 2005-08-18
CA2553884A1 (en) 2005-08-18
AU2005211165A8 (en) 2011-07-14
CA2553884C (en) 2013-06-25
AU2005211165B8 (en) 2011-07-14
NO20063781L (no) 2006-10-24
AU2005211165B2 (en) 2011-02-24
RU2350124C2 (ru) 2009-03-27
KR20060132667A (ko) 2006-12-21

Similar Documents

Publication Publication Date Title
BRPI0507253A (pt) composição nutricional para melhorar as condições da pele e prevenir doenças de pele
Ishrat et al. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type
Moretti et al. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress
Xia et al. Differential effects of quercetin on hippocampus-dependent learning and memory in mice fed with different diets related with oxidative stress
US6902739B2 (en) Methods for treating joint inflammation, pain, and loss of mobility
Ahmad et al. Effect of dietary sesame oil as antioxidant on brain hippocampus of rat in focal cerebral ischemia
Ciobica et al. The effects of pergolide on memory and oxidative stress in a rat model of Parkinson’s disease
BR9916450A (pt) Composição tópica, método cosmético para tratar e/ ou prevenir condições de pele, e, uso de ácido linoleico conjugado, e/ ou derivados do mesmo
AU2002315558A1 (en) Methods for treating joint inflammation, pain, and loss of mobility
Lin et al. Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains
Trevizol et al. Comparative study between two animal models of extrapyramidal movement disorders: prevention and reversion by pecan nut shell aqueous extract
Ye et al. In vivo antioxidant and anti‐skin‐aging activities of ethyl acetate extraction from Idesia polycarpa defatted fruit residue in aging mice induced by D‐galactose
Thirupathi et al. Modulatory effects of taurine on metabolic and oxidative stress parameters in a mice model of muscle overuse
CN103479552A (zh) 抗皱舒活眼霜及制备方法
Zhu et al. Effect of different tea polyphenol products on egg production performance, egg quality and antioxidative status of laying hens
Hong et al. Effect of vitamin E supplement in diet on antioxidant ability of testis in Boer goat
El-Awdan et al. Alleviation of haloperidol induced oxidative stress in rats: Effects of sucrose vs grape seed extract
Adebayo et al. Comparative study on the influence of fluoride on lipid peroxidation and antioxidants levels in the different brain regions of well-fed and protein undernourished rats
Brandner et al. Caffeine improves barrier function in male skin
Derin et al. Effect of alpha-lipoic acid on visual evoked potentials in rats exposed to sulfite
Monteiro et al. Ovariectomy impairs spatial memory: prevention and reversal by a soy isoflavone diet
Martins et al. Synergistic neurotoxicity induced by methylmercury and quercetin in mice
Dixit et al. Protective role of exogenous α-lipoic acid (ALA) on hippocampal antioxidant status and memory function in rat pups exposed to sodium arsenite during the early post-natal period
Toader et al. Neuroprotective strategy in an experimental newborn rat model of brain ischemia and hypoxia: Effects of Resveratrol and hypothermia
Ozdemir et al. In vitro effect of some plant extracts on acetylcholinesterase enzyme in human erythrocytes and serum

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]

Free format text: REF. A RPI 2031 DE 08/12/2009, POR TER SIDO INDEVIDO.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ARTIGO 8O C/C 11 E 13, 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/375 (2006.01), A23L 33/115 (2016.01), A61K